Cerion’s executive management team has a proven history of building successful companies from the ground up with a focus on the introduction of groundbreaking products and services to the global marketplace. Our team has the optimal mix of deep-science experience and proven business acumen, which sets us apart from other companies in the advanced materials industry.

Mr. Mertz is the Chief Executive Officer of Cerion, and a member of the company’s board of directors.

Mertz joined Cerion as its Chief Financial Officer in January of 2009, taking on responsibility for the company’s overall financial management. In June of 2012, he was appointed Chief Executive Officer.

Prior to joining Cerion, Mr. Mertz was the Chief Operating Officer of the Festival Network, a company who develops and acquires multi-day music festivals in geographically unique destinations around the globe. During his tenure, he was responsible for the strategic direction and growth of operations in nineteen (19) distinct markets across three (3) continents.

Prior to Festival Network, Mertz served as the Chief Executive Officer of Intermedia, a nationally recognized firm responsible for producing large-scale events, product launches, meetings, conferences and award shows on behalf of Fortune 500 / 1000 companies and consumer brands such as Goldman Sachs, Hewlett Packard, Hearst Publishing, Fairchild Publishing, Pitney Bowes, SIFMA, Chase, Citibank, GRAMMY Awards, Univision, Vera Wang and Tommy Hilfiger amongst others.

Mr. Winslow oversees all strategic partnerships with industry and government in addition to working closely with R&D on the identification of new product applications.

A seasoned business development executive, previous to joining Cerion Mr. Winslow led the creation and development of The Dreaming Tree Wine brand for Constellation Brands, the world’s leading premium wine company. A collaboration with renowned musician Dave Matthews, The Dreaming Tree became the most successful celebrity-associated wine brand launch in history, doubling estimates while surpassing 200,000 cases sold in its first year alone. The Dreaming Tree has received numerous industry awards including being named 2012’s Best New Wine Product by Market Watch along with a Top 30 Momentum Wine Brand by Symphony IRI.

Before his time with Constellation Brands, Mr. Winslow was the Senior Vice President, Brand Partnerships for Generate, a production company in Los Angeles founded by Jordan Levin, the former CEO of The WB Network and funded by Fuse Capital, an investment group led by former AOL Chairman Jonathan Miller and former Yahoo! CEO, Ross Levinsohn. While at Generate, Mr. Winslow was responsible for developing strategic partnerships with companies such as Taco Bell, Absolut Vodka, and Unilever along with digital distributors such as YouTube and MSN.

Previously Winslow was one of the earliest employees of Los Angeles- based ad agency Ignited Minds where he served as Vice President of Business Development, leading the growth of the agency from 15 people and $17 million in billings to 125 people and over $100 million in billings in only four years. While at Ignited Minds, he initiated and developed relationships with brands such as Nike, Jose Cuervo, Cadbury Schweppes, Motorola, NBC Universal, 20th Century Fox, THQ, Levi Strauss, Sony Electronics, and Turner Broadcast Station (TBS) among numerous other nationally and internationally respected companies.

He began his career as a Senior Account Executive at Eric Mower & Associates in Rochester, NY. Winslow received his B.S. in Advertising and Communications from the Roy H. Park School of Communications at Ithaca College.

Mr. Singer is part of the original group that founded Cerion in 2007 and is currently Executive Vice President in charge of Manufacturing with responsibility for chemical plant operations, new product scale-up, and capital programs. Prior to Cerion, Mr. Singer spent 16 years at Eastman Kodak as an R&D/Manufacturing project manager in imaging nanoparticle production, attaining certification as a Lean Manufacturing Six Sigma Black Belt Practitioner. He has managed startups and accreditation of chemical manufacturing operations on-site at Kodak plants in the USA, Canada, England, and China. In addition, he has led million-dollar cost reduction programs, new equipment design projects across eight countries, and new product commercialization efforts. As part of his product-process research, Mr. Singer has received three U.S. Patents in chemical process technology. Mr. Singer is a graduate of Lehigh University (highest honors, Phi Beta Kappa) with a B.S. in Mechanical Engineering.

Brad Stadler earned a B.S. in Molecular Biology and a Concentration in Chemical Engineering from Lehigh University in 1997. Following several years as a research assistant at Harvard Medical School/Beth Israel Deaconess Hospital in Boston, MA, he entered graduate school and received his Ph.D. in Biomedical Sciences at the University of Massachusetts Medical School in 2007, while studying the role of regulatory RNAs produced during Adenovirus infection. Following graduate school, Dr. Stadler performed four years of postdoctoral training at the Institute for Stem Cell and Regenerative Medicine at the University of Washington, examining the contribution of microRNAs to stem cell maintenance and development. Joining Cerion Enterprises in 2011, Dr. Stadler now works in research and development for biologic and therapeutic applications of the company's nanoparticle technologies, including neurodegenerative disease therapeutics (Cerion NRx), nucleic acid transfection, antimicrobials and drug delivery.

Dr. Sandford received a B.S. in Chemistry (summa cum laude, Phi Beta Kappa) from Hope College in 1990 and a Ph.D. in Inorganic Chemistry from the University of California at Berkeley. After graduation, he joined Eastman Kodak Co. as a research scientist precipitating and sensitizing photographic emulsions with controlled particle sizes and morphologies resulting in improved film performance. Subsequent projects included synthesis, characterization and commercialization of novel antimicrobial actives, nano particulate metal oxide catalysts and silver-based battery materials resulting in new business, spin-off and licensing opportunities in addition to 4 U.S. Patents and 9 recently filed patent applications. Dr. Sandford provided technical support and guidance to new business ventures within Eastman Kodak including use of nanoparticles for medical imaging, high refractive index plastics for lenses and improved materials for longer life batteries. Most recently, he led the technical team for the Specialty Materials business that over the past two years commercialized several new antimicrobial products for the textile and plastics markets, provided technical support for new and existing products and developed novel technologies to address new market segments.